These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 31067690)

  • 1. Sodium-Hydrogen Exchanger Isoform-1 Inhibition: A Promising Pharmacological Intervention for Resuscitation from Cardiac Arrest.
    Gazmuri RJ; Radhakrishnan J; Ayoub IM
    Molecules; 2019 May; 24(9):. PubMed ID: 31067690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse postresuscitation myocardial effects elicited by buffer-induced alkalemia ameliorated by NHE-1 inhibition in a rat model of ventricular fibrillation.
    Lamoureux L; Radhakrishnan J; Mason TG; Kraut JA; Gazmuri RJ
    J Appl Physiol (1985); 2016 Nov; 121(5):1160-1168. PubMed ID: 27633736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limiting sarcolemmal Na+ entry during resuscitation from ventricular fibrillation prevents excess mitochondrial Ca2+ accumulation and attenuates myocardial injury.
    Wang S; Radhakrishnan J; Ayoub IM; Kolarova JD; Taglieri DM; Gazmuri RJ
    J Appl Physiol (1985); 2007 Jul; 103(1):55-65. PubMed ID: 17431086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AVE4454B--a novel sodium-hydrogen exchanger isoform-1 inhibitor--compared less effective than cariporide for resuscitation from cardiac arrest.
    Radhakrishnan J; Kolarova JD; Ayoub IM; Gazmuri RJ
    Transl Res; 2011 Feb; 157(2):71-80. PubMed ID: 21256459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful ventricular defibrillation by the selective sodium-hydrogen exchanger isoform-1 inhibitor cariporide.
    Gazmuri RJ; Ayoub IM; Hoffner E; Kolarova JD
    Circulation; 2001 Jul; 104(2):234-9. PubMed ID: 11447092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basic biology and pharmacology of the cardiac sarcolemmal sodium/hydrogen exchanger.
    Avkiran M
    J Card Surg; 2003; 18 Suppl 1():3-12. PubMed ID: 12691374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational basis for use of sodium-hydrogen exchange inhibitors in myocardial ischemia.
    Avkiran M
    Am J Cardiol; 1999 May; 83(10A):10G-17G; discussion 17G-18G. PubMed ID: 10482175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the efficiency of Na+/Ca2+ exchanger or Na+/H+ exchanger inhibition and their combination in reducing coronary reperfusion-induced arrhythmias.
    Szepesi J; Acsai K; Sebok Z; Prorok J; Pollesello P; Levijoki J; Papp JG; Varro A; Toth A
    J Physiol Pharmacol; 2015 Apr; 66(2):215-26. PubMed ID: 25903952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Empagliflozin decreases myocardial cytoplasmic Na
    Baartscheer A; Schumacher CA; Wüst RC; Fiolet JW; Stienen GJ; Coronel R; Zuurbier CJ
    Diabetologia; 2017 Mar; 60(3):568-573. PubMed ID: 27752710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium ion/hydrogen ion exchange inhibition: a new pharmacologic approach to myocardial ischemia and reperfusion injury.
    Levitsky J; Gurell D; Frishman WH
    J Clin Pharmacol; 1998 Oct; 38(10):887-97. PubMed ID: 9807968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial protection during ventricular fibrillation by inhibition of the sodium-hydrogen exchanger isoform-1.
    Gazmuri RJ; Ayoub IM; Kolarova JD; Karmazyn M
    Crit Care Med; 2002 Apr; 30(4 Suppl):S166-71. PubMed ID: 11940795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Na(+)/H(+) exchanger: a target for cardiac therapeutic intervention.
    Karmazyn M; Sawyer M; Fliegel L
    Curr Drug Targets Cardiovasc Haematol Disord; 2005 Aug; 5(4):323-35. PubMed ID: 16101565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial protection during resuscitation from cardiac arrest.
    Gazmuri RJ; Ayoub IM; Kolarova J
    Curr Opin Crit Care; 2003 Jun; 9(3):199-204. PubMed ID: 12771670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the Na(+)/H(+) exchanger attenuates phase 1b ischemic arrhythmias and reperfusion-induced ventricular fibrillation.
    Gumina RJ; Daemmgen J; Gross GJ
    Eur J Pharmacol; 2000 May; 396(2-3):119-24. PubMed ID: 10822064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium-hydrogen exchange inhibition during ventricular fibrillation: Beneficial effects on ischemic contracture, action potential duration, reperfusion arrhythmias, myocardial function, and resuscitability.
    Ayoub IM; Kolarova J; Yi Z; Trevedi A; Deshmukh H; Lubell DL; Franz MR; Maldonado FA; Gazmuri RJ
    Circulation; 2003 Apr; 107(13):1804-9. PubMed ID: 12665493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of cardiac sarcolemmal Na+/H+ exchanger activity by endogenous ligands. Relevance to ischemia.
    Avkiran M; Haworth RS
    Ann N Y Acad Sci; 1999 Jun; 874():335-45. PubMed ID: 10415545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcolemmal Na+/H+ exchanger activity and expression in human ventricular myocardium.
    Yokoyama H; Gunasegaram S; Harding SE; Avkiran M
    J Am Coll Cardiol; 2000 Aug; 36(2):534-40. PubMed ID: 10933369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of intracellular calcium concentration in cardiomyocytes by inhibition of sarcolemmal Na+/H+ exchanger.
    Saini HK; Dhalla NS
    Am J Physiol Heart Circ Physiol; 2006 Dec; 291(6):H2790-800. PubMed ID: 16861694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic inhibition of na(+)/h(+)-exchanger in the heart.
    Baartscheer A
    Curr Vasc Pharmacol; 2006 Jan; 4(1):23-9. PubMed ID: 16472174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of caspase-3 may not contribute to postresuscitation myocardial dysfunction.
    Radhakrishnan J; Ayoub IM; Gazmuri RJ
    Am J Physiol Heart Circ Physiol; 2009 Apr; 296(4):H1164-74. PubMed ID: 19234092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.